Meetings: Nonprescription Drugs Advisory Committee; correction,

[Federal Register: July 17, 1998 (Volume 63, Number 137)]

[Notices]

[Page 38657-38658]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr17jy98-74]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Nonprescription Drugs Advisory Committee: Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Nonprescription Drugs Advisory Committee. This meeting was announced in the Federal Register of June 26, 1998 (63 FR 34902). The amendment is being made to cancel the entire session on July 28, 1998. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Rhonda W. Stover or Angie Whitacre, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443- 0572 in the Washington, DC area), code 12541.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 26, 1998 (63 FR 34902), FDA announced that a meeting of the Nonprescription Drugs Advisory Committee would be held on July 28 and 29, 1998.

  1. On page 34902, in the third column, the ``Date and Time'' portion is amended to read as follows:

    Date and Time: The meeting will be held on July 29, 1998, 8:30 a.m. to 5 p.m.

  2. On page 34902, beginning in the third column, the ``Agenda'' portion is amended by removing the first paragraph.

    [[Page 38658]]

  3. On page 34903, in the first column, under the ``Procedure'' portion, in the ninth line, ``July 28 and 29'' is corrected to read ``July 29''.

    Dated: July 10, 1998. Michael A. Friedman, Deputy Commissioner for Operations.

    [FR Doc. 98-19031Filed7-17-98; 8:45 am]

    BILLING CODE 4160-01-F

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT